Skip to content

Advanced Breast Cancer and Lifestyle Exercise Study

Advanced Breast Cancer and Lifestyle Exercise Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03148886
Acronym
ABLE
Enrollment
51
Registered
2017-05-11
Start date
2016-10-31
Completion date
2018-01-31
Last updated
2018-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Breastcancer

Keywords

Physical activity

Brief summary

About 5% of breast cancers are metastatic at diagnosis and 20-30% of localized breast cancer become secondarily metastatic.Thanks to recent therapeutic advances, the median survival ranges between 12 months in 1970 and 18 to 24 months in 2000. However, patients suffer from many detrimental symptoms such as fatigue, pain related to treatment and metastasis. The physical, biological, psychological and clinical benefits of physical activity (PA) during treatment in patients with localized breast cancer have been widely demonstrated. Numerous studies investigated the effect of PA in non-metastatic breast cancer, but to our knowledge, only four interventional studies worldwide focused on the implementation of PA in patients with metastatic breast cancer.It seems appropriate to investigate the feasibility of PA intervention with patients with metastatic breast cancer to see if the observed effects in localized breast cancer are confirmed in metastatic breast cancer population. The ABLE study is an interventional cohort designed to assess the feasibility of a 6-month adapted physical activity intervention, performed under real life conditions in patients with metastatic breast cancer.

Interventions

OTHERPA intervention

The program is individualized according to age, fitness level, place of residence, access to adapted specific training group or associations, PA preferences and wishes of each participant. Patients are informed of the recommendations in terms of PA, and the target of 150min per week in order to maintain health benefits. Patients are asked to walk at least 30 minutes per day and increase their activities into daily routine. Several individual strategies are established with the patients to attain their objectives and increase their daily life PA. Withings® PA trackers have been used to provide an incentive effect to increase PA, to measure the number of steps per day and make people think about their PA. Patients wore a Withings Go® wristband PA tracker throughout the whole study and had in real time a feedback on their number of steps per day. A 7 mL blood sample is collected at baseline (D1) and at the end of the 6-month study (M6) for the biological study.

Sponsors

Claude Bernard University
CollaboratorOTHER
Centre Leon Berard
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 78 Years
Healthy volunteers
No

Inclusion criteria

* aged 18 to 78 years old, * newly diagnosed with a metastatic breast cancer (i.e. within the last 3 months) * treated in the CLB by chemotherapy, and/or radiotherapy and/or hormonotherapy and/or targeted therapy. * ECOG Performance status \<2, * being French-speaking * able to complete questionnaires and follow instructions in French * valid health insurance affiliation. * medical certificate of no contraindications to exercise physical activity

Exclusion criteria

* untreated brain metastases * uncontrolled cardiac disease, * contraindications to PA, * unable to be followed for medical, social, familial, geographical or psychological reasons over the study duration, * deprivation of liberty by court or administrative decision * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients achieving the physical activity program recommendations6 months150 min per week of moderate PA assessed by the IPAQ

Secondary

MeasureTime frameDescription
Investigate the effects of a PA intervention on fitness level6 monthsIPAQ in MET-min per week
Investigate the effects of a PA intervention on quality of life6 monthsEORTC QLQ-C30
Investigate the effects of a PA intervention on fatigue6 monthsPIPER scale
Variation of oxidative stress6 months7mL blood sample is collected at baseline and at the end of the study
Investigate the barriers and facilitators of adherence to a PA program6 monthsSpecific questionnaire
Investigate the effects of a PA intervention on changes in anthropometrics6 monthsBMI in kilograms per m²
Investigate the effects of a PA intervention on social deprivation6 monthsEPICES score

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026